G-MAB
USPTO Trademark Record · Serial No. 85321324
Trademark details
It was initially claimed by Sorrento Therapeutics Inc. on 20110515.
That brand applies to the following goods and services:Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen, Therapeutic pharmaceutical for the treatment of cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen.
Currently that trademark is represented by trademark attorney(s): Jeffrey B. Oster.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the G-MAB trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
